Pinar Karaca-Mandic, PhD

Articles by Pinar Karaca-Mandic, PhD

The Potential Impact of CAR T-Cell Treatment Delays on Society

ByJulia Thornton Snider, PhD,Michelle Brauer, BS,Rebecca Kee, BA,Katharine Batt, MD, MSc,Pinar Karaca-Mandic, PhD,Jie Zhang, PhD,Dana P. Goldman, PhD

August 13th 2019

Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.

Latest Updated Articles

The Potential Impact of CAR T-Cell Treatment Delays on Society
Published: August 13th 2019 | Updated:

Pinar Karaca-Mandic, PhD

Articles by Pinar Karaca-Mandic, PhD

The Potential Impact of CAR T-Cell Treatment Delays on Society

Latest Updated Articles

Trending on CGTlive®

Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA

CGTLive®’s Weekly Rewind – December 19, 2025

The Implications of the Final Data From Hemgenix’s HOPE-B Trial

Emily Brown, MGC, CGC, on Models for Expanding Access to Cardiac Genetic Counseling